Hörnblad Y, Ripe E, Leideman T
Scand J Respir Dis. 1978 Jun;59(3):160-6.
In a controlled double-blind cross-over study in 15 patients with reversible bronchial obstruction hexoprenaline (Ipradol, 0.20 mg/puff) and terbutaline (Bricanyl, 0.25 mg/puff) when administered as metered aerosol in a dosage of one puff followed by two puffs 30 min later produced the same maximum improvement of ventilatory function. However, after inhalation of terbutaline a more sustained broncholytic effect was obtained than after hexoprenaline. Similar results were obtained in six patients after doubling the dose of each agent. The influence on pulse rate and blood pressure was negligible with either agent. The amplitude of finger tremor was measured after 2 + 4 puffs. No significant changes in mean values occurred after either of the two agents although after hexoprenaline an increase in amplitude of more than 100% was recorded in two out of six patients 30 min after the second dose.
在一项针对15名可逆性支气管阻塞患者的对照双盲交叉研究中,己双肾上腺素(异丙喘宁,每喷0.20毫克)和特布他林(博利康尼,每喷0.25毫克)以定量气雾剂形式给药,剂量为1喷,30分钟后再喷2喷,二者产生的通气功能最大改善程度相同。然而,吸入特布他林后获得的支气管溶解作用比己双肾上腺素更持久。将每种药物剂量加倍后,6名患者也得到了类似结果。两种药物对脉搏率和血压的影响均可忽略不计。在喷2次加4次后测量手指震颤幅度。两种药物给药后平均值均未发生显著变化,不过在第二次给药30分钟后,己双肾上腺素使6名患者中的2名震颤幅度增加超过100%。